Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients

Andrea Haddad, Issam Raad, Mohamed Ben Moussa et al.|Cancers|2024

Cited by 9